Early-stage Clinical Characterization of Malignant Pleural Mesothelioma

about

Early-stage Clinical Characterization of Malignant Pleural Mesothelioma

Item

http://www.wikidata.org/entity/Q58765920

description

wetenschappelijk artikel

@nl

wissenschaftlicher Artikel

@de

name

Early-stage Clinical Characterization of Malignant Pleural Mesothelioma

@en

Early-stage Clinical Characterization of Malignant Pleural Mesothelioma

@nl

type

Item

label

Early-stage Clinical Characterization of Malignant Pleural Mesothelioma

@en

Early-stage Clinical Characterization of Malignant Pleural Mesothelioma

@nl

prefLabel

Early-stage Clinical Characterization of Malignant Pleural Mesothelioma

@en

Early-stage Clinical Characterization of Malignant Pleural Mesothelioma

@nl

P1476

Early-stage Clinical Characterization of Malignant Pleural Mesothelioma

@en

P2093

Hiroshi Doi

http://www.w3.org/2001/XMLSchema#string

Koji Mikami

http://www.w3.org/2001/XMLSchema#string

Kozo Kuribayashi

http://www.w3.org/2001/XMLSchema#string

Norihiko Funaguchi

http://www.w3.org/2001/XMLSchema#string

Seiki Hasegawa

http://www.w3.org/2001/XMLSchema#string

Takashi Kijima

http://www.w3.org/2001/XMLSchema#string

Takashi Yokoi

http://www.w3.org/2001/XMLSchema#string

Teruhisa Takuwa

http://www.w3.org/2001/XMLSchema#string

Toshiyuki Minami

http://www.w3.org/2001/XMLSchema#string

Yoshiki Negi

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems

Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment.

Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapy.

Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma.

Intensity-modulated radiotherapy after extrapleural pneumonectomy in the combined-modality treatment of malignant pleural mesothelioma.

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.

Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study.

Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.

Is malignant pleural mesothelioma a surgical disease? A review of 83 consecutive extra-pleural pneumonectomies.

P304

1169-1174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21873/INVIVO.11360

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P698

30150440

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

P932

6199612

http://www.w3.org/2001/XMLSchema#string